Back
Amplify Weight Loss Drug & Treatment ETF Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
$25.04
Seasonality Move:
-5.53%
7 Day Trial
ALL ACCESS PASS
$
7
Amplify Weight Loss Drug & Treatment ETF Stock Forecast
-
Is Amplify Weight Loss Drug & Treatment ETF Stock Undervalued?The current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $25.41. The Score for THNR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
THNR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Amplify Weight Loss Drug & Treatment ETF Stock Go Up Next Year?
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Stock Rating
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Stock Price History
Stock Information
Stock Info
Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:
52-Week Data
52-Week High:
27.28
52-Week Low:
18.56
Prediction Charts
Market Cap:
0
Price in USD:
25.41
Volume:
244
Beta:
0.74
Technical Analysis
SMA50:
26.01
SMA100:
25.21
SMA200:
24.09
52-Wk Change:
9.46%
Stock Predictions
-
Is Amplify Weight Loss Drug & Treatment ETF stock public?Yes, Amplify Weight Loss Drug & Treatment ETF is a publicly traded company.
-
What is the Amplify Weight Loss Drug & Treatment ETF stock quote today?The Amplify Weight Loss Drug & Treatment ETF stock price is 25.41 USD today.
-
How to buy Amplify Weight Loss Drug & Treatment ETF stock online?You can buy Amplify Weight Loss Drug & Treatment ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-12 | 26.35 | 26.31 | 26.35 | 26.31 |
| Feb-13 | 26.54 | 26.54 | 26.54 | 26.49 |
| Feb-17 | 26.44 | 26.54 | 26.54 | 26.41 |
| Feb-18 | 26.82 | 26.53 | 26.82 | 26.47 |
| Feb-19 | 26.70 | 26.38 | 26.70 | 26.38 |
| Feb-20 | 26.46 | 26.48 | 26.61 | 26.46 |
| Feb-23 | 26.20 | 26.26 | 26.26 | 26.20 |
| Feb-24 | 26.23 | 26.14 | 26.23 | 26.14 |
| Feb-25 | 26.10 | 26.00 | 26.15 | 25.98 |
| Feb-26 | 25.67 | 25.63 | 25.70 | 25.38 |
| Feb-27 | 25.80 | 25.96 | 25.96 | 25.80 |
| Mar-2 | 25.61 | 25.61 | 25.61 | 25.61 |
| Mar-3 | 24.86 | 25.08 | 25.08 | 24.86 |
| Mar-4 | 24.97 | 25.41 | 25.41 | 24.97 |
Amplify Weight Loss Drug & Treatment ETF Earnings
Data Unavailable
Amplify Weight Loss Drug & Treatment ETF Forecast Revenue Growth
Data Unavailable
* Amplify Weight Loss Drug & Treatment ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.